Evaluation of dosing time-related anti-hypertensive efficacy of valsartan in patients with type 2 diabetes.

Clin Exp Hypertens · 2011 · PMC4673599 · PMID 21166600

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

While there was no difference in the decrease in BP among the regimens of valsartan, but urine albumin excretion was significantly decreased after administration in the evening, suggesting that inhibition of the nocturnal activation of an RA system in the kidney may be significant.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.